Lymphoproliferation and hyper-IgM as the first manifestation of activated phosphoinositide 3-kinase δ syndrome: A case report
Activated phosphoinositide 3-kinase δ syndrome is an inborn error of immunity due to mutations within the genes responsible for encoding PI3Kδ subunits. This syndrome results in an excessive activation of the phosphoinositide 3-kinase signaling pathway. Gainof-function mutations in the gene PIK3R1 (...
Saved in:
| Main Authors: | Mónica Fernandes-Pineda, Andrés F. Zea-Vera |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Instituto Nacional de Salud
2024-12-01
|
| Series: | Biomédica: revista del Instituto Nacional de Salud |
| Subjects: | |
| Online Access: | https://revistabiomedica.org/index.php/biomedica/article/view/7436 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dual variants of uncertain significance in a case of hyper-IgM syndrome: implications for diagnosis and management
by: Nourhen Agrebi, et al.
Published: (2025-06-01) -
Modeling, optimization, and comparable efficacy of T cell and hematopoietic stem cell gene editing for treating hyper‐IgM syndrome
by: Valentina Vavassori, et al.
Published: (2021-01-01) -
Detection of Toxoplasma gondii IgM in a Sample of Rheumatoid Arthritis Patients Receiving Biological Therapy
by: Ikram Khazal Qasim Al- hasso, et al.
Published: (2025-04-01) -
Pattern of IgM and IgG changes depending on the pathological process duration in patients with autoimmune thyroiditis
by: R. R. Rahimova, et al.
Published: (2024-10-01) -
Successful treatment of a CLL associated IgM hyper-viscosity syndrome: A rare case
by: Toufic Tannous, et al.
Published: (2024-01-01)